Geneva Capital Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123M | Buy |
2,082,788
+249,141
| +14% | +$14.7M | 2.06% | 15 |
|
|
2025
Q1 | $134M | Buy |
1,833,647
+17,810
| +1% | +$1.3M | 2.51% | 10 |
|
|
2024
Q4 | $150M | Buy |
1,815,837
+217,707
| +14% | +$18M | 2.61% | 9 |
|
|
2024
Q3 | $114M | Buy |
1,598,130
+18,117
| +1% | +$1.3M | 1.91% | 13 |
|
|
2024
Q2 | $108M | Buy |
1,580,013
+8,127
| +0.5% | +$557K | 1.97% | 14 |
|
|
2024
Q1 | $84.3M | Buy |
1,571,886
+149,987
| +11% | +$8.05M | 1.48% | 22 |
|
|
2023
Q4 | $75.8M | Sell |
1,421,899
-325
| -0% | -$17.3K | 1.43% | 26 |
|
|
2023
Q3 | $70.6M | Sell |
1,422,224
-15,527
| -1% | -$771K | 1.49% | 26 |
|
|
2023
Q2 | $85.6M | Buy |
1,437,751
+4,013
| +0.3% | +$239K | 1.69% | 19 |
|
|
2023
Q1 | $81.2M | Buy |
1,433,738
+9,412
| +0.7% | +$533K | 1.65% | 17 |
|
|
2022
Q4 | $106M | Buy |
1,424,326
+18,555
| +1% | +$1.38M | 2.38% | 6 |
|
|
2022
Q3 | $83.7M | Buy |
1,405,771
+53,773
| +4% | +$3.2M | 1.93% | 11 |
|
|
2022
Q2 | $75.9M | Buy |
1,351,998
+142,013
| +12% | +$7.97M | 1.75% | 13 |
|
|
2022
Q1 | $89.3M | Sell |
1,209,985
-12,074
| -1% | -$891K | 1.72% | 12 |
|
|
2021
Q4 | $88.2M | Sell |
1,222,059
-26,015
| -2% | -$1.88M | 1.42% | 20 |
|
|
2021
Q3 | $95.6M | Sell |
1,248,074
-8,452
| -0.7% | -$648K | 1.62% | 15 |
|
|
2021
Q2 | $97.4M | Sell |
1,256,526
-20,922
| -2% | -$1.62M | 1.59% | 15 |
|
|
2021
Q1 | $78.8M | Buy |
1,277,448
+322,334
| +34% | +$19.9M | 1.34% | 24 |
|
|
2020
Q4 | $62.3M | Buy |
955,114
+26,034
| +3% | +$1.7M | 1.06% | 36 |
|
|
2020
Q3 | $46M | Buy |
929,080
+22,562
| +2% | +$1.12M | 0.95% | 45 |
|
|
2020
Q2 | $43.3M | Buy |
906,518
+24,876
| +3% | +$1.19M | 0.94% | 44 |
|
|
2020
Q1 | $37.5M | Buy |
+881,642
| New | +$37.5M | 1.07% | 37 |
|